Amgen To Present At The 39th Annual J.P. Morgan Healthcare Conference
Amgen (NASDAQ:AMGN) will present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 11:50 a.m. PT. CEO Robert A. Bradway will lead the presentation, which will be accessible live via Amgen's website. A replay will be available for 90 days post-event. As a leading biotechnology company, Amgen is focused on advancing therapies for serious illnesses by leveraging human genetics to address unmet medical needs. The company has a robust pipeline and aims to enhance health outcomes for patients globally.
- None.
- None.
THOUSAND OAKS, Calif., Jan. 6, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 39th Annual J.P. Morgan Healthcare Conference at 11:50 a.m. PT on Monday, Jan. 11, 2021. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.
About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631 (media)
Arvind Sood, 805-447-1060 (investors)
View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301202269.html
SOURCE Amgen
FAQ
When will Amgen present at the J.P. Morgan Healthcare Conference?
Who is presenting for Amgen at the healthcare conference?
Where can I watch the Amgen presentation live?
How long will the replay of the Amgen presentation be available?
What is Amgen's focus in biotechnology?
